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Abstract—Several flaviviruses are important human pathogens, 
including dengue virus, a disease against which neither a 
vaccine nor specific antiviral therapies currently exist. QSAR 
study was carried out with the purpose of searching new 
competitive dengue inhibitors with similar properties to the 
existence inhibitors (i.e. data set). The approach began with the 
development of rigorously validated QSAR model obtained 
using multiple linear regression analysis (MLRA) with 
conventional correlation coefficient (r2) value of 0.82 and 
cross-validated correlation coefficient (r2CV) value of 0.65 and 
partial least squares (PLS) technique with r2 value of 0.82 and 
r2CV value of 0.74. The model showed a good correlative and 
predictive ability having a predictive correlation coefficient 
(r2pred) of 0.80. The validated QSAR models were then 
employed in mining the database which consisted of 45,917 
compounds. The degree of similarity (based on Euclidean 
distance and Tanimoto coefficient) between the compounds 
probed from the data set and those in the database were 
calculated using the same set of descriptors in the QSAR model. 
A total of 7 compounds were short-listed and finally the 
inhibition constant of these compounds were calculated and 
predicted to be competitive dengue inhibitors. 
Keywords- QSAR; dengue DEN2 NS2B/NS;, Euclidean 
distance; Tanimoto coefficient  
I.  INTRODUCTION 
Dengue virus (DV) and West Nile virus (WNV) are 
closely related members of the flaviviridae family. Dengue is 
a serious emerging disease which has become a global health 
burden in the recent decades. This virus is transmitted to man 
by a domestic mosquito, Aedes aegypti as the principal 
vector although some other species such as Aedes albopictus 
are also important [1]. WNV is transmitted by Culex 
mosquitos [2] and it is widely distributed around the world. 
In humans, WNV infections are usually asymptomatic or 
may cause a mild flu-like illness for a few days.  This 
infection is as the West Nile fever.  Currently, there are no 
approved vaccines to fight these diseases. In addition, there 
is also no known anti-viral therapy for dengue fever. 
Both DV and WNV have a positive single strand RNA 
which codes for a single polyprotein precursor. The 
polyprotein precursor contains three structural proteins (C 
(capsid), M (membrane) and E (envelope) and seven non 
structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B 
and NS5) [3, 4]. The DEN2 NS2B/NS3 and WNV 
NS2B/NS3 serine protease hold promise as a target for 
therapeutic intervention with small molecule as drugs [5]. 
The increasing spread and severity of DENV and WNV 
infections emphasize the importance of drug discovery 
strategies that is efficient and cost-effective. There are many 
approaches in developing new compounds that exhibit 
certain biological activities. In this paper, we present a 
method based on application of quantitative structure activity 
relationship (QSAR) models to screen a large chemical 
database. 
QSAR study is based on a numerical description of 
molecular structure and uses statistics to obtain quantitative 
correlation to its properties. This methodology assumes that 
suitable sampling for these structural descriptors would 
provide all the information needed to understand their 
properties [6, 7]. Based on the premise that activity is related 
to the structure, these models can then be used to predict the 
activity of compounds not included in the model 
development stage. 
In this study, we have developed QSAR models 
correlating structural characteristics of some panduratin A 
derivatives and pyrazole derivative with their inhibition 
constant value. The models were then applied to mining a 
larger chemical database to discover a set of credible 
competitive dengue DEN2 NS2B/NS3 inhibitors. 
II. RESEARCH METHODOLOGIES 
A. Data Set for Analysis 
Structures of 30 inhibitors used in this study were 
obtained from the literature [5, 8, 9] and from previous 
results in our lab. Compounds with a variety of Ki value (μM) 
were used as data set to develop the QSAR model.  The data 
set was divided into a training set (20 compounds) for QSAR 
model development and a prediction set (10 compounds) for 
model validation. The training set selection was performed 
by first sorting the list in increasing value of biological 
activity. Next, the list of compounds were divided into three 
groups (i.e. group I consisting of compounds nos. 1-10, 
group II with compounds nos. 11-20 and group III consisting 
of compounds nos. 21-30). The compounds in group I and III 
were assigned to the training set and compounds in group II 
were assigned to the prediction set. This method was chosen 
to produce more representative samples in the training set. 
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 B. Development of QSAR Model 
Molecular structures of those ligands were sketched 
using the ChemDraw 6.0 software (Cambridge) while Corina 
in TSAR 3.3 (Accelrys) software package was used to 
convert the structures into their 3D conformation.  The 
geometries of these molecules were optimized using the 
Cosmic module of TSAR. The calculation were terminated 
when the energy difference or the energy gradient become 
smaller than 1 x 10-5 and 1 x 10-10 kcal/mol, respectively. 
Molecular descriptors were generated using TSAR 3.3 
(Accelrys) for each compound. 316 descriptors were 
obtained from this calculation. These descriptors were then 
reduced to a smaller set of descriptors.  These set should be 
information rich but as small as possible. 
Correlation matrix was applied to select the best subset of 
descriptors to be included in the model by eliminating 
descriptors that are highly correlated with each other. Next 
step involves scaling descriptors which requires a thorough 
manipulation since there may be underlying relationship 
between these descriptors and it may not be possible to 
foresee the effects of this process. Range scaling also helps 
to avoid disproportional weightings of descriptors upon the 
Euclidean distance calculations in multidimensional 
descriptors space. The scaling was calculated as follow: 
iy  =  
( )
( ) ( )xx
xxi
minmax
min
−
−
  (1) 
Where, iy  is the scaled value, ix  is the original value while 
min ( x ) is the minimum of the collection of x  object and 
max ( x ) is the maximum of the collection of x  objects. 
The selected descriptors were used to build the QSAR 
model. In this study, QSAR models were developed using 
multiple linear regression analysis (MLRA) and partial least 
squares (PLS) technique. The main goal of QSAR model 
development is to find the best set of descriptors which will 
produce a stable QSAR model and have the ability to predict 
properties of unknown compounds. 
For the MLRA technique, values for F-to-enter and F-to-
leave were set to 4. Cross-validation analysis was performed 
using the leave-one-out (LOO) method where one compound 
is removed from the dataset and its activity is calculated 
using the model derived from the rest of the dataset. The 
cross-validated r2 and conventional r2 that resulted in the 
lowest error of prediction were chosen. Unless otherwise 
stated, the default values for the other QSAR parameters 
were used. 
The last step in QSAR model development is model 
validation.  It is important to evaluate the robustness and the 
predictive capacity or validity of the model before using the 
model on the interpretation and prediction of the biological 
activity. The biological activities of compounds in the 
predicted set were calculated using the model produced by 
the training set.  
C. Database Mining and Similarity Searching 
Thirty compounds in the data set with inhibition constant 
values (Ki) were selected as probes to calculate the degree of 
similarity with compounds in a larger database. Euclidean 
distance was employed to measure this similarity using the 
same set of descriptors that appeared in the QSAR model. 
The degree of similarity (i.e. Euclidean distance) can be 
calculated as follows: 
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=
−
N
n
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1
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where, dij is the distance between any two compounds, Xin 
and Xjn are the values of the nth descriptor for compounds i 
and j. Compounds in the database within the chosen 
similarity cutoff value (0.5 Euclidean distance units in a 
multidimensional space) were considered as hits and can be 
further investigated. Another similarity concept, the 
Tanimoto similarity coefficient, was also applied. For real-
valued properties the Tanimoto similarity is defined as: 
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Where, iAX  is the value of property i of molecule A, 
and iBX  is the value of property i  of molecule B. 
The concept of applicability domain or similarity 
threshold that is specific to each particular QSAR model was 
applied to the database mining [10, 11] to avoid making 
prediction for compounds that differ substantially from the 
training set molecules. The similarity threshold was 
calculated as follow: 
DT   =   y  +  Zσ        (4)    
 
Where y the average Euclidean distance between each 
compound, σ is the standard deviation of these Euclidean 
distances and Z is an arbitrary parameter to control the 
significance level (0.5). If the distance of a particular 
compound from the probe molecules is less than this 
threshold value, the prediction is considered reliable. 
III. RESULTS AND DISCUSSION 
A. QSAR Modeling 
The equation for the QSAR model is: 
Log 1/Ki = -1.19 * verloop B3 (subst. 2) – 2.20 * inertia 
moment 2 length – 0.92 * vamp    LUMO – 0.78 * vamp 
polarization YZ + 4.01 (5) 
The cross-validated coefficient (r2CV) defines the 
goodness of prediction whereas the non-cross-validated 
conventional correlation coefficient (r2) indicates the 
goodness of fit of a QSAR model [12]. The F test value 
stands for the degree of statistical confidence. The statistical 
output of the MLRA model is presented in Table 1, a cross 
validated coefficient of 0.65 was obtained using the leave 
one out cross validation procedure.  
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 TABLE I.    STATISTICAL OUTPUT OF MLRA MODEL 
Statistical output Value 
R2 0.82 
Cross validation  r2 (CV) 0.65 
F- value 20.67 
F-probability 3.42e-007 
Standard error of estimate 
(SEE) 
0.37 
Residual sum of square (RSS) 2.46 
Predictive sum of square 
(PRESS) 
4.86 
The best QSAR model developed using MLRA 
technique has r2 of 0.82 and r2 (CV) of 0.65. This indicates a 
very good internal predictive capability of the developed 
model. The model also exhibited a non cross-validated 
correlation coefficient of 0.82. The high value of this 
parameter adds to its usefulness as a predictive tool.  
From the QSAR model as presented above, the 
electrostatic parameter (i.e. Vamp LUMO and Vamp 
polarization YZ) are negatively correlated with the inhibitory 
constant. The energy of LUMO is directly related to the 
electron affinity and characterizes the susceptibility of the 
molecule toward attack by nucleophiles.  Both HOMO and 
LUMO energies have been considered as indicators of drug 
activity [13]. The inhibitory activity improves with an 
increase in the electrostatic parameter. The statistical 
significance of the parameter derived from QSAR model is 
presented in Table 2 and brief descriptions about those 
descriptors are shown in Table 3.  
The development of QSAR model by using MLRA 
technique can be accepted, if the models have r2(CV) greater 
than 0.5 and r2 greater than 0.6 [14]. Thus with r2 value of 
0.82 and r2 (CV) value of 0.65, the model generated above is 
presumably capable of predicting the biological activities of 
compounds which were not included in the model 
development process. A plot of experimental vs. predicted Ki 
is shown in Figure 1 while a plot of standard residual vs. 
predicted value (residual plot) is presented in Figure 2. These 
two plots are important to graphically observe the predictive 
capability of QSAR. Shorter height of the residual and the 
fact that the training set molecules are on or near the best fit 
line, as shown in Figure 1, further add to the usefulness of 
the developed QSAR. 
 
TABLE II.  STATISTICAL SIGNIFICANCE OF PARAMETER 
 
Descriptors Regression 
coefficienta 
Jackife  
SEb 
Covariance 
SEc 
t-valued t-probabilitye 
Verloop B3 -1.19 0.53 0.29 -4.15 6.1 x10-4 
Inertia moment 
 2 length 
-2.20 0.24 0.25 -8.79 6.2 x 10-5 
Vamp LUMO -0.93 0.22 0.29 -3.18 5.1 x 10-3 
Vamp 
polarization YZ 
-0.78 0.33 0.29 -2.66 1.6 x 10-2 
a The regression coefficient for each variable in the equation 
b An estimate of the standard error of each regression coefficient derived from a Jacknife procedure on the final regression model 
c Estimate of the standard error of each regression coefficient derived from the covariance matrix 
d Significance of each variable included in the final model 
e Statistical significance for t-values 
TABLE III.  DESCRIPTORS WHICH WERE INCLUDED IN THE MLRA 
MODEL 
Descriptor Symbol Explanation 
Verloop 
parameter 
Verloop B3  The distance from the axis of 
the attachment bond, 
measured perpendicularly to 
the edge of the substituents.  
Molecular 
attributes 
Inertia moment 2 
length 
Indicates the strength and 
orientation behaviors of 
molecule in an electrostatic 
field.  
Electrostatic 
parameter 
Vamp lumo, 
vamp 
polarization YZ 
Properties of molecule arising 
from the interaction between a 
charge probe such as positive 
unit point reflecting a proton 
and target molecule. 
 
 
PLS technique has also been used to develop the QSAR 
model. PLS also can be used quite effectively as a tool for 
interpreting QSAR model and that the information extracted 
is much more detailed [15]. The PLS routine in TSAR stop 
the iteration if a model has one the following criterion [16, 
17]: the lowest value of predictive sum of squares (PRESS) 
or when PRESS value starts to increase. In this study, the 
QSAR model generated using PLS has four dimensions.  The 
PLS dimension three was selected as the best PLS QSAR 
model with r2 value of 0.82 and r2 (CV) value of 0.74. The 
highest r2(CV) and the lowest PRESS value of this 
dimension indicated that this model is more stable and 
suitable for predicting the inhibitory constant of compounds 
that were not included in the training set. The statistical 
output of this PLS model is presented in Table 4. 
 
 
Figure 1.  Plot of predicted value vs. experimental Ki for MLRA technique 
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Figure 2.  Plot of predicted value vs. standard residual for MLRA model 
TABLE IV.    STATISTICAL OUTPUT OF PLS MODEL 
Statistical output value 
Fraction of variance 0.82 
Cross validation r2(CV) 0.74 
Residual sum of square (RSS) 3.93 
Predictive sum of square (PRESS) 5.69 
 
Both models were validated by predicting the inhibitory 
activity of 10 compounds excluded during the model 
development process (prediction set). The correlation 
coefficient (r2) between predicted and experimental values 
was also calculated. A predictive correlation coefficient r2 
value of 0.80 obtained for both of these QSAR models the 
usefulness of the developed QSAR models in predicting 
activities of molecules not included in its derivation. 
Alternatively, to further evaluate the significance of the 
developed model is to test it for statistical stability. For this, 
the standard error of estimate and predictive residual sum of 
squares may be employed. Low values of the standard error 
of estimate (SEE) at 0.37 and predictive residual sum of 
squares (PRESS) for the MLRA model at 4.86 further add to 
the statistical significance of the developed model. However, 
the obtained PLS model (i.e. PLS dimension three) has 
higher PRESS value of 5.69.  This seemed to indicate the 
PLS model to be unstable for predicting unknown 
compounds in the prediction set.  
B. Database Mining 
A set of compounds in the data set with their inhibitory 
constant (Ki, µM) were used as the similarity probes for 
database mining. The degree of similarity based on 
Euclidean distance and Tanimoto coefficient between 
compounds in the data set and those in database were 
calculated using the same set of descriptors used in the 
QSAR models. Since the limiting value of the distance is 0.5, 
compounds with the distances higher than 0.5 were rejected 
and classified as outliers. 
In the first round of screening, out of the 45,917 
compounds in the database [18], 526 compounds were found 
to be within the chosen similarity cutoff value obtained from 
the 30 probe molecules. These compounds were further 
subjected to consensus hits criteria (i.e. molecules that 
consistently appear in both models), reducing the candidate 
to 469 compounds. Subsequently, the 469 compounds were 
subjected to the applicability domain criteria (similarity 
threshold) and the number of possible candidates was further 
narrowed down to 51 compounds. The inhibition constants 
of these 51 candidates were predicted by using the two best 
QSAR models where each model has its specific 
applicability domain criteria. Using the Tanimoto similarity 
coefficient, 486 compounds were selected as initial hits and 
468 compounds were selected by both QSAR models. 
Applying the applicability domain, the numbers of possible 
candidates were further narrowed to 34 compounds. 
Prediction of activity should be made within the domain 
of an appropriately validated QSAR. To achieve this, the 
applicability domain of a model should be defined, a QSAR 
model based on the mechanism of action approach tend to 
rely on expert judgment to define the domain. The 
applicability domain may be defined by the general 
properties on a more detailed structural basis for specific 
toxicities. For a prediction to be valid, the compound must 
fall within the applicability domain of the models since the 
applicability domain would prevent predictions for 
compounds that differ substantially from the training set 
molecules [19, 20]. Applicability domain also can be used to 
exclude compounds that are too dissimilar to the training set 
to make any reliable prediction of their activity. The list of 
selected compounds earlier (i.e. 51 compounds and 34 
compounds) were further refined by finding compounds that 
appear within both similarity distances. This resulted in as 
many as 7 compounds (Table 6).  
IV. CONCLUSIONS 
  Quantitative structure activity relationship (QSAR)        
approach has been used to develop models with high 
predictive power to predict the inhibition constant (Ki) value 
of compounds that are not included in the training set. The 
MLRA technique has been used to develop a good QSAR 
model which revealed that the inhibitory activity of the 
DEN2 virus to be predominantly influenced by electrostatic 
properties. The application of QSAR model in database 
mining has enabled us to predict potential compounds as new 
leads as competitive inhibitors for NS2B/NS3 serine protease. 
The list can be further refined by restricting to compounds 
which are similar in structure to those in the training set. 
Currently, laboratory experiments are being carried out to 
validate these QSAR models.  
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TABLE V.  SELECTED COMPOUNDS WITH THEIR PREDICTED KI VALUE 
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